首页> 美国卫生研究院文献>other >Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells
【2h】

Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells

机译:环境和化学治疗剂诱导人类造血干/祖细胞中引起白血病基因重排的基因断裂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hematopoietic stem and progenitor cells (HSPCs) give rise to all of the cells that make up the hematopoietic system in the human body, making their stability and resilience especially important. Damage to these cells can severely impact cell development and has the potential to cause diseases, such as leukemia. Leukemia-causing chromosomal rearrangements have largely been studied in the context of radiation exposure and are formed by a multi-step process, including an initial DNA breakage and fusion of the free DNA ends. However, the mechanism for DNA breakage in patients without previous radiation exposure is unclear. Here, we investigate the role of non-cytotoxic levels of environmental factors, benzene, and diethylnitrosamine (DEN), and chemotherapeutic agents, etoposide, and doxorubicin, in generating DNA breakage at the patient breakpoint hotspots of the MLL and CBFB genes in human HSPCs. These conditions represent exposure to chemicals encountered daily or residual doses from chemotherapeutic drugs. Exposure of HSPCs to non-cytotoxic levels of environmental chemicals or chemotherapeutic agents causes DNA breakage at preferential sites in the human genome, including the leukemia-related genes MLL and CBFB. Though benzene, etoposide, and doxorubicin have previously been linked to leukemia formation, this is the first study to demonstrate a role for DEN in the generation of DNA breakage at leukemia-specific sites. These chemical-induced DNA breakpoints coincide with sites of predicted topoisomerase II cleavage. The distribution of breakpoints by exposure to non-cytotoxic levels of chemicals showed a similar pattern to fusion breakpoints in leukemia patients. Our findings demonstrate that HSPCs exposed to non-cytotoxic levels of environmental chemicals and chemotherapeutic agents are prone to topoisomerase II-mediated DNA damage at the leukemia-associated genes MLL and CBFB. These data suggest a role for long-term environmental chemical or residual chemotherapeutic drug exposure in generation of DNA breakage at sites with a propensity to form leukemia-causing gene rearrangements.
机译:造血干细胞和祖细胞(HSPC)产生了构成人体造血系统的所有细胞,因此其稳定性和适应性尤为重要。对这些细胞的损害会严重影响细胞发育,并有可能引起疾病,例如白血病。引起白血病的染色体重排已在辐射暴露的背景下进行了广泛的研究,并通过多步骤过程形成,包括初始DNA断裂和游离DNA末端融合。但是,尚无先前辐射暴露的患者中DNA断裂的机制尚不清楚。在这里,我们调查环境因素,苯和二乙基亚硝胺(DEN)以及化学治疗剂,依托泊苷和阿霉素的非细胞毒性水平在人类HSPCs的MLL和CBFB基因患者断点热点处产生DNA断裂中的作用。 。这些条件表示每天接触的化学药品或化学治疗药物的残留剂量。将HSPC暴露于环境化学物质或化学治疗剂的非细胞毒性水平会导致人类基因组中优先位点的DNA断裂,包括白血病相关基因MLL和CBFB。尽管苯,依托泊苷和阿霉素以前与白血病的形成有关,但这是第一个证明DEN在白血病特异性位点DNA断裂产生中的作用的研究。这些化学诱导的DNA断裂点与预测的拓扑异构酶II裂解的位点一致。通过暴露于非细胞毒性水平的化学物质而产生的断点分布与白血病患者的融合断点相似。我们的研究结果表明,暴露于非细胞毒性水平的环境化学物质和化学治疗剂的HSPC在白血病相关基因MLL和CBFB上容易受到拓扑异构酶II介导的DNA损伤。这些数据表明长期环境化学或残留化学治疗药物暴露在易于形成引起白血病的基因重排的位点DNA断裂中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号